NanJing Pharmaceutical Company Limited

Shanghai Stock Exchange 600713.SS

NanJing Pharmaceutical Company Limited Return on Capital Employed (ROCE) for the year ending December 31, 2023: 13.70%

NanJing Pharmaceutical Company Limited Return on Capital Employed (ROCE) is 13.70% for the year ending December 31, 2023, a -5.14% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

NanJing Pharmaceutical Company Limited Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 14.45%, a -6.86% change year over year.
NanJing Pharmaceutical Company Limited Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 15.51%, a -4.42% change year over year.
NanJing Pharmaceutical Company Limited Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 16.23%, a -24.89% change year over year.
NanJing Pharmaceutical Company Limited Return on Capital Employed (ROCE) for the year ending December 31, 2019 was 21.61%, a 13.54% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

Shanghai Stock Exchange: 600713.SS

NanJing Pharmaceutical Company Limited

CEO	Mr. Liang Zhang
IPO Date	July 1, 1996
Location	China
Headquarters	Building A
Employees	4,903
Sector	Health Care
Industries Drugstores & Retail Pharmacies Pharmaceuticals Retail & Wholesale

Description

NanJing Pharmaceutical Company Limited engages pharmaceutical wholesale and retail businesses in China. It also operates approximately 510 pharmacy retail stores and an e-commerce platform. The company was founded in 1951 and is based in Nanjing, China.

Key trends

Past 5 years